Salvage Radiosurgery for Brain Metastases:
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Salvage Radiosurgery for Brain Metastases:

› Forums › General Melanoma Community › Salvage Radiosurgery for Brain Metastases:

  • Post
    • December 19, 2013 at 1:15 pm
    JerryfromFauq
    Participant

    Salvage Radiosurgery for Brain Metastases: Prognostic Factors to Consider in Patient Selection

    Purpose

    Stereotactic radiosurgery (SRS) is offered to patients for recurrent brain metastases after prior brain radiation therapy (RT), but few studies have evaluated the efficacy of salvage SRS or factors to consider in selecting patients for this treatment. This study reports overall survival (OS), intracranial progression-free survival (PFS), and local control (LC) after salvage SRS, and factors associated with outcomes.

    Methods and Materials

    This is a retrospective review of patients treated from 2009 to 2011 with salvage SRS after prior brain RT for brain metastases. Survival from salvage SRS and from initial brain metastases diagnosis (IBMD) was calculated. Univariate and multivariable (MVA) analyses included age, performance status, recursive partitioning analysis (RPA) class, extracranial disease control, and time from initial RT to salvage SRS.

    Results

    There were 106 patients included in the analysis with a median age of 56.9 years (range 32.5-82 years). A median of 2 metastases were treated per patient (range, 1-12) with a median dose of 21 Gy (range, 12-24) prescribed to the 50% isodose. With a median follow-up of 10.5 months (range, 0.1-68.2), LC was 82.8%, 60.1%, and 46.8% at 6 months, 1 year, and 3 years, respectively. Median PFS was 6.2 months (95% confidence interval [CI] = 4.9-7.6). Median OS was 11.7 months (95% CI = 8.1-13) from salvage SRS, and 22.1 months from IBMD (95% CI = 18.4-26.8). On MVA, age (P=.01; hazard ratio [HR] = 1.04; 95% CI = 1.01-1.07), extracranial disease control (P=.004; HR = 0.46; 95% CI = 0.27-0.78), and interval from initial RT to salvage SRS of at least 265 days (P=.001; HR = 2.46; 95% CI = 1.47-4.09) were predictive of OS.

    Conclusions

    This study demonstrates that patients can have durable local control and survival after salvage SRS for recurrent brain metastases. In particular, younger patients with controlled extracranial disease and a durable response to initial brain RT are likely to benefit from salvage SRS.

Viewing 5 reply threads
  • Replies
      • December 19, 2013 at 2:01 pm
      SBeattie
      Participant

      Thank you Jerry for keeping up with the literature!

      • December 19, 2013 at 2:01 pm
      SBeattie
      Participant

      Thank you Jerry for keeping up with the literature!

      • December 19, 2013 at 2:01 pm
      SBeattie
      Participant

      Thank you Jerry for keeping up with the literature!

      • December 19, 2013 at 2:50 pm
      POW
      Participant

      Yes, thanks Jerry. As a science geek, I get frustrated when I can not read the full length article– abstracts don't usually have enough detail for me properly evaluate the data. However, working with what we have…

      This article says that IF one's melanoma responds well to whole brain radiation (WBR) and IF there is little disease progression in the rest of the body (presumably through some type of treatment) then SRS of a few new brain mets can significantly lengthen one's lifespan.

      I think we all assumed that, but it's nice to know that it is official.  

        • December 27, 2013 at 3:50 am
        JerryfromFauq
        Participant

        I hate abstracts and summaries too.  Wish I could afford to Officially jooin the full article world.  Have seen many questionson different pllaces by new people asking about  SRS and WBR.  Several people have been directed to WBR as the initial seffort when they have anly had a few known brain tumors.  For myself, WBR would be much more of a last resort than a beginning aaction.

        • December 27, 2013 at 3:50 am
        JerryfromFauq
        Participant

        I hate abstracts and summaries too.  Wish I could afford to Officially jooin the full article world.  Have seen many questionson different pllaces by new people asking about  SRS and WBR.  Several people have been directed to WBR as the initial seffort when they have anly had a few known brain tumors.  For myself, WBR would be much more of a last resort than a beginning aaction.

        • December 27, 2013 at 3:50 am
        JerryfromFauq
        Participant

        I hate abstracts and summaries too.  Wish I could afford to Officially jooin the full article world.  Have seen many questionson different pllaces by new people asking about  SRS and WBR.  Several people have been directed to WBR as the initial seffort when they have anly had a few known brain tumors.  For myself, WBR would be much more of a last resort than a beginning aaction.

      • December 19, 2013 at 2:50 pm
      POW
      Participant

      Yes, thanks Jerry. As a science geek, I get frustrated when I can not read the full length article– abstracts don't usually have enough detail for me properly evaluate the data. However, working with what we have…

      This article says that IF one's melanoma responds well to whole brain radiation (WBR) and IF there is little disease progression in the rest of the body (presumably through some type of treatment) then SRS of a few new brain mets can significantly lengthen one's lifespan.

      I think we all assumed that, but it's nice to know that it is official.  

      • December 19, 2013 at 2:50 pm
      POW
      Participant

      Yes, thanks Jerry. As a science geek, I get frustrated when I can not read the full length article– abstracts don't usually have enough detail for me properly evaluate the data. However, working with what we have…

      This article says that IF one's melanoma responds well to whole brain radiation (WBR) and IF there is little disease progression in the rest of the body (presumably through some type of treatment) then SRS of a few new brain mets can significantly lengthen one's lifespan.

      I think we all assumed that, but it's nice to know that it is official.  

Viewing 5 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.